Activity-based costing evaluation of a [18F]-fludeoxyglucose positron emission tomography study

The cost of FDG-PET is mainly influenced by the cost of the radiopharmaceutical. Therefore, the latter rather than the operational time should be reduced in order to improve its cost-effectiveness.